Cara Therapeutics | CARA - Чистый доход





Чистый доход Изменить Дата
Acadia Pharmaceuticals USD 31.5M 27.86M 2026-06
Alterity Therapeutics Limited AUD -6.3M 525.41K 2025-12
Cara Therapeutics USD -6.8M 1.28M 2026-03
Cassava Sciences USD -10.33M 2.21M 2026-03
Chugai Pharma JPY 116.33B 913M 2026-06
Cipla INR 7.89B 2.34B 2026-06
Clal Biotechnology ILS -6.17M 15.56M 2022-12
Compugen USD -7.67M 64.51M 2026-03
CSL USD 401M 96.5M 2025-12
Grifols EUR 114.37M 34.03M 2025-12
Halozyme Therapeutics USD 229.91M 79.86M 2026-06
J&J USD 5.53B 299M 2026-06
Neurocrine Biosciences USD 144.4M 53.5M 2026-06
Pacira USD 4.65M 1.74M 2026-06
Pfizer USD -248M 2.94B 2026-06
RedHill Biopharma USD -1.54M 0 2024-06
Supernus Pharmaceuticals USD -58.37M 56.08M 2026-06
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12